Nutrition 21 Retains Dresdner Kleinwort Wasserstein

PURCHASE, N.Y., Feb 02, 2006 (BUSINESS WIRE) -- Nutrition 21, Inc. (NXXI) today announced that the company has retained the investment banking firm Dresdner Kleinwort Wasserstein to assist the company in evaluating possible strategic alternatives.

Paul Intlekofer, COO and CFO of Nutrition 21 said, "We are pleased with the progress we have made in our initial efforts to sell branded products directly to retailers.

Dresdner Kleinwort Wasserstein will explore possible alternatives that would enhance our financial capabilities to further develop our retail distribution strategy or that would otherwise maximize shareholder value."

About Nutrition 21

Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The Company markets Chromax(R) chromium picolinate,, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome(R), Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at

Safe Harbor Provision

This press release may contain certain forward-looking statements. The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based largely on the Company's current expectations and are subject to a number of risks and uncertainties, including without limitation: the effect of the expiration of patents; regulatory issues; uncertainty in the outcomes of clinical trials; changes in external market factors; changes in the Company's business or growth strategy or an inability to execute its strategy due to changes in its industry or the economy generally; the emergence of new or growing competitors; various other competitive factors; and other risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended June 30, 2005 and subsequent reports on Form 10-Q. Actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements contained in this press release will in fact occur. Additionally, the Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.